Page 2 - U.S. Growth Pharmaceuticals & Biotech Stocks

UPDATED Sep 29, 2025

Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

735 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
JAGX
Jaguar Health
US$2.113.9%-93.7%US$4.7mUS$25.50PB0.8xE71.8%n/a
DARE
Daré Bioscience
US$2.092.5%-35.5%US$27.5mUS$10.75PE-1.5xE71.2%n/a
PHAT
Phathom Pharmaceuticals
US$11.33-3.5%-37.3%US$820.5mUS$21.38PS6.9xE71.0%n/a
NRSN
NeuroSense Therapeutics
US$1.25-1.6%-1.6%US$31.1mUS$14.00PE-3.6xE70.6%n/a
SNDX
Syndax Pharmaceuticals
US$15.564.5%-19.2%US$1.4bUS$37.50PS17.2xE70.5%n/a
BFRI
Biofrontera
US$0.97-4.2%-27.2%US$10.2mUS$6.50PE-0.6xE70.5%n/a
SCPH
scPharmaceuticals
US$5.670.7%24.3%US$303.8mUS$12.12PS6.1xE70.3%n/a
GLSI
Greenwich LifeSciences
US$10.16-13.9%-29.3%US$141.8mUS$42.00PB96.2xE70.3%n/a
EOLS
Evolus
US$6.14-2.7%-62.1%US$387.5mUS$18.83PS1.4xE70.2%n/a
CBUS
Cibus
US$1.31-3.7%-59.8%US$70.5mUS$14.40PS14.2xE69.9%n/a
TLSI
TriSalus Life Sciences
US$4.67-4.3%1.3%US$234.4mUS$11.36PS6.5xE69.8%n/a
SRRA
Sierra Oncology
US$54.990.06%179.4%US$1.3bUS$55.00PB5.1xE69.5%n/a
APLS
Apellis Pharmaceuticals
US$22.65-3.6%-21.5%US$2.8bUS$37.47PS3.8xE69.5%n/a
PSTV
Plus Therapeutics
US$0.8396.3%-43.1%US$61.3mUS$7.88PS15.5xE69.2%n/a
CAPR
Capricor Therapeutics
US$7.4121.7%-51.3%US$324.1mUS$20.60PS25.3xE69.2%n/a
BBIO
BridgeBio Pharma
US$51.960.8%104.1%US$9.6bUS$66.32PS42.1xE69.0%n/a
HYFT
MindWalk Holdings
US$1.73-13.9%170.7%US$83.1mUS$4.00PS4.4xE69.0%n/a
MREO
Mereo BioPharma Group
US$1.965.9%-52.3%US$308.6mUS$7.10PS623.7xE68.9%n/a
PGEN
Precigen
US$3.63-5.7%283.3%US$1.0bUS$8.25PS249.2xE68.9%n/a
TVTX
Travere Therapeutics
US$24.04-5.5%71.8%US$2.3bUS$36.00PS6.4xE68.8%n/a
RNXT
RenovoRx
US$1.18-9.2%11.3%US$43.2mUS$5.63PS65.3xE68.6%n/a
OSTX
OS Therapies
US$2.01-9.0%-28.2%US$64.9mUS$12.06PB12.9xE68.6%n/a
ZLAB
Zai Lab
US$32.93-0.7%36.4%US$3.5bUS$55.41PS8.6xE68.6%n/a
GERN
Geron
US$1.31-1.5%-71.1%US$823.0mUS$3.63PS5.1xE68.5%n/a
Page 2 of 31